Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pestic Biochem Physiol ; 204: 106066, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39277382

RESUMO

Difenoconazole (DIF) is frequently used for the management of fungal infections in fruit and vegetables and excessive residues in the aquatic environment can have adverse effects on fish such as growth inhibition. A treatment based on the dietary additive quercetin (QUE) is a promising approach to positively regulate the state of fish growth. This study focused on whether and how QUE alleviated DIF-induced growth inhibition in fish. In this study, carp were exposed to DIF (0.3906 mg/L) for consecutive 30 d, which showed growth inhibition. Disruption of the intestinal barrier led to elevated levels of intestinal lipopolysaccharide (LPS) and an inflammatory response. Through the intestinal-brain axis, LPS entered the brain where it disrupted the blood-brain barrier, triggered neuroinflammation, caused brain cell apoptosis, and damaged nerves in addition to other things. The dietary supplementation of QUE (400 mg/kg) reduced the levels of LPS in the intestinal and brain, while reducing inflammation and increasing the expression of appetite factors, thereby reducing growth inhibition in carp. This work provided evidence for QUE from the intestinal-brain axis perspective as a potential candidate for alleviating growth inhibition in fish.


Assuntos
Encéfalo , Carpas , Dioxolanos , Intestinos , Quercetina , Animais , Carpas/metabolismo , Quercetina/farmacologia , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Intestinos/efeitos dos fármacos , Dioxolanos/farmacologia , Triazóis/farmacologia , Lipopolissacarídeos/farmacologia , Barreira Hematoencefálica/efeitos dos fármacos , Barreira Hematoencefálica/metabolismo , Fungicidas Industriais/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA